PHARMAMAR HA OPTADO POR LA RETIRADA DE LA SOLICITUD DE AUTORIZACIÓN DE COMERCIALIZACIÓN DE APLIDIN ( PLITIDEPSIN ) ... WITHDRAWAL OF APPLICATIÓN FOR THE MARKETING AUTHORISATION OF APLIDIN ( PLITIDEPSIN ) JULY 23 , 2025 .
09 septiembre 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) Today Announced That the Company Will Webcast its Corporate Presentations at The Following Virtual Investor Conferences .
